A detailed history of First Horizon Advisors, Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 11,773 shares of TMO stock, worth $5.9 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
11,773
Previous 12,194 3.45%
Holding current value
$5.9 Million
Previous $6.74 Million 7.98%
% of portfolio
0.2%
Previous 0.21%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$531.86 - $624.21 $223,913 - $262,792
-421 Reduced 3.45%
11,773 $7.28 Million
Q2 2024

Jul 19, 2024

SELL
$541.52 - $599.02 $530,148 - $586,440
-979 Reduced 7.43%
12,194 $6.74 Million
Q1 2024

Apr 26, 2024

SELL
$528.82 - $599.43 $88,312 - $100,104
-167 Reduced 1.25%
13,173 $7.66 Million
Q4 2023

Feb 06, 2024

SELL
$431.41 - $532.94 $1.29 Million - $1.59 Million
-2,984 Reduced 18.28%
13,340 $7.08 Million
Q3 2023

Oct 27, 2023

BUY
$498.29 - $574.41 $187,357 - $215,978
376 Added 2.36%
16,324 $8.26 Million
Q2 2023

Aug 03, 2023

SELL
$508.46 - $591.13 $206,943 - $240,589
-407 Reduced 2.49%
15,948 $8.32 Million
Q1 2023

May 15, 2023

SELL
$535.0 - $604.82 $417,835 - $472,364
-781 Reduced 4.56%
16,355 $9.43 Million
Q4 2022

Feb 10, 2023

SELL
$484.71 - $571.37 $742,575 - $875,338
-1,532 Reduced 8.21%
17,136 $9.44 Million
Q3 2022

Nov 09, 2022

SELL
$507.19 - $604.49 $1.22 Million - $1.45 Million
-2,406 Reduced 11.42%
18,668 $9.47 Million
Q2 2022

Aug 02, 2022

SELL
$500.9 - $612.21 $2.4 Million - $2.93 Million
-4,789 Reduced 18.52%
21,074 $11.4 Million
Q1 2022

May 10, 2022

SELL
$524.0 - $644.92 $2.68 Million - $3.3 Million
-5,124 Reduced 16.54%
25,863 $15.3 Million
Q4 2021

Feb 09, 2022

SELL
$569.0 - $667.24 $254,912 - $298,923
-448 Reduced 1.43%
30,987 $20.7 Million
Q3 2021

Nov 15, 2021

SELL
$509.53 - $609.78 $749,009 - $896,376
-1,470 Reduced 4.47%
31,435 $18 Million
Q3 2021

Nov 09, 2021

BUY
$509.53 - $609.78 $15 Million - $18 Million
29,481 Added 861.01%
32,905 $18.8 Million
Q2 2021

Aug 09, 2021

BUY
$441.0 - $508.24 $9,261 - $10,673
21 Added 0.62%
3,424 $1.73 Million
Q1 2021

May 11, 2021

BUY
$439.85 - $518.83 $13,635 - $16,083
31 Added 0.92%
3,403 $1.55 Million
Q4 2020

Feb 11, 2021

SELL
$435.06 - $527.66 $89,622 - $108,697
-206 Reduced 5.76%
3,372 $1.57 Million
Q3 2020

Nov 12, 2020

SELL
$359.77 - $441.52 $57,203 - $70,201
-159 Reduced 4.25%
3,578 $1.58 Million
Q2 2020

Jul 31, 2020

SELL
$275.2 - $362.34 $29,721 - $39,132
-108 Reduced 2.81%
3,737 $1.35 Million
Q1 2020

May 05, 2020

SELL
$255.3 - $340.05 $26,806 - $35,705
-105 Reduced 2.66%
3,845 $1.09 Million
Q4 2019

Jan 07, 2020

SELL
$271.93 - $328.04 $7,614 - $9,185
-28 Reduced 0.7%
3,950 $1.28 Million
Q3 2019

Oct 23, 2019

SELL
$268.46 - $305.43 $135,035 - $153,631
-503 Reduced 11.23%
3,978 $1.16 Million
Q2 2019

Aug 05, 2019

SELL
$257.51 - $295.55 $146,780 - $168,463
-570 Reduced 11.28%
4,481 $0
Q1 2019

Apr 26, 2019

SELL
$212.17 - $273.72 $36,493 - $47,079
-172 Reduced 3.29%
5,051 $0
Q4 2018

Feb 11, 2019

SELL
$208.47 - $251.98 $519,924 - $628,438
-2,494 Reduced 32.32%
5,223 $1.17 Million
Q3 2018

Nov 05, 2018

BUY
$205.57 - $244.32 $1.41 Million - $1.68 Million
6,879 Added 820.88%
7,717 $0
Q3 2018

Nov 05, 2018

SELL
$205.57 - $244.32 $1.48 Million - $1.76 Million
-7,200 Reduced 89.57%
838 $0
Q2 2018

Aug 07, 2018

BUY
$203.14 - $219.53 $625,468 - $675,932
3,079 Added 62.09%
8,038 $0
Q1 2018

May 02, 2018

SELL
$192.98 - $224.11 $37,824 - $43,925
-196 Reduced 3.8%
4,959 $0
Q4 2017

Jan 25, 2018

BUY
$182.03 - $200.37 $69,899 - $76,942
384 Added 8.05%
5,155 $0
Q3 2017

Nov 09, 2017

SELL
$171.74 - $194.04 $6,697 - $7,567
-39 Reduced 0.81%
4,771 $0
Q2 2017

Aug 14, 2017

BUY
N/A
4,810
4,810 $0

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $196B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.